SE8800886D0 - Immunoglobulin conjugates - Google Patents

Immunoglobulin conjugates

Info

Publication number
SE8800886D0
SE8800886D0 SE8800886A SE8800886A SE8800886D0 SE 8800886 D0 SE8800886 D0 SE 8800886D0 SE 8800886 A SE8800886 A SE 8800886A SE 8800886 A SE8800886 A SE 8800886A SE 8800886 D0 SE8800886 D0 SE 8800886D0
Authority
SE
Sweden
Prior art keywords
immunoglobulin conjugates
antigen
conjugates
immunoglobulin
ida
Prior art date
Application number
SE8800886A
Other languages
English (en)
Other versions
SE8800886L (sv
SE503402C2 (sv
Inventor
Ian F C Mckenzie
Geoffrey A Pietersz
Mark J Smyth
Original Assignee
Erba Farmitalia
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia, Univ Melbourne filed Critical Erba Farmitalia
Publication of SE8800886D0 publication Critical patent/SE8800886D0/sv
Publication of SE8800886L publication Critical patent/SE8800886L/sv
Publication of SE503402C2 publication Critical patent/SE503402C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
SE8800886A 1987-03-11 1988-03-11 Immunglobulinkojugat, förfarande för framställning av densamma samt komposition innehållande densamma SE503402C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPI080387 1987-03-11
AUPI295587 1987-07-07

Publications (3)

Publication Number Publication Date
SE8800886D0 true SE8800886D0 (sv) 1988-03-11
SE8800886L SE8800886L (sv) 1989-09-12
SE503402C2 SE503402C2 (sv) 1996-06-10

Family

ID=25643244

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8800886A SE503402C2 (sv) 1987-03-11 1988-03-11 Immunglobulinkojugat, förfarande för framställning av densamma samt komposition innehållande densamma

Country Status (29)

Country Link
US (1) US5798097A (sv)
JP (1) JP2736255B2 (sv)
KR (1) KR0130906B1 (sv)
CN (1) CN1045621C (sv)
AT (1) AT395375B (sv)
AU (1) AU622105B2 (sv)
BE (1) BE1001051A4 (sv)
CA (1) CA1329156C (sv)
CH (1) CH678815A5 (sv)
CZ (1) CZ161288A3 (sv)
DE (1) DE3808166C2 (sv)
DK (1) DK173792B1 (sv)
ES (1) ES2006109A6 (sv)
FI (1) FI98706C (sv)
FR (1) FR2612074B1 (sv)
GB (1) GB2203154B (sv)
GR (1) GR1000059B (sv)
HU (1) HU205266B (sv)
IE (1) IE64781B1 (sv)
IL (1) IL85688A0 (sv)
IT (1) IT8819746A0 (sv)
MY (1) MY103231A (sv)
NL (1) NL8800610A (sv)
NO (1) NO178954C (sv)
NZ (1) NZ223834A (sv)
PT (1) PT86960B (sv)
RU (1) RU2106147C1 (sv)
SE (1) SE503402C2 (sv)
YU (1) YU46858B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6824777B1 (en) * 1992-10-09 2004-11-30 Licentia Ltd. Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
WO2000021560A1 (en) * 1998-10-09 2000-04-20 Ludwig Institute For Cancer Research Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
WO2002049672A2 (en) * 2000-12-21 2002-06-27 Mcgill University Conjugates of antibodies and anticancer drugs
ATE359300T1 (de) 2001-01-19 2007-05-15 Ludwig Inst Cancer Res Flt4 (vegfr-3) als ein ziel für krebs darstellung und anti-krebs-behandlung
CA2522700A1 (en) * 2003-04-18 2004-11-04 Cytovia, Inc. Methods of treating diseases responsive to induction of apoptosis and screening assays
GB0511266D0 (en) * 2005-06-02 2005-07-13 Trust Chemical compounds
US20080108138A1 (en) * 2006-06-13 2008-05-08 Vermette Patrick Bioactive compositions and their use in cell patterning
SI2646470T1 (sl) 2010-11-30 2017-05-31 F. Hoffmann-La Roche Ag Protitelesa proti receptorjem antitransferina in njihova uporaba za prenos terapevtskega enoverižnega variabilnega fragmenta (scfv) prek krvno-možganske pregrade
US9745558B2 (en) 2013-02-18 2017-08-29 Vegenics Pty Limited VEGFR-3 ligand binding molecules and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT343812B (de) * 1975-01-22 1978-06-26 Farmaceutici Italia Verfahren zur herstellung von neuen optisch aktiven daunosaminylderivaten von anthracyclinonen
AT346838B (de) * 1975-01-22 1978-11-27 Farmaceutici Italia Verfahren zur herstellung von neuen optisch aktiven anthracyclinonen
AT343811B (de) * 1975-01-22 1978-06-26 Farmaceutici Italia Verfahren zur herstellung von neuen optisch aktiven anthracyclinonen
GB1500421A (en) * 1975-01-22 1978-02-08 Farmaceutici Italia Optically active anthracyclinones
GB1511680A (en) 1975-11-18 1978-05-24 Farmaceutici Italia Daunosaminyl anthracyclinones
GB1541436A (en) * 1976-02-02 1979-02-28 Searle & Co Immunological materials
US4950738A (en) * 1984-09-13 1990-08-21 Cytogen Corporation Amine derivatives of anthracycline antibiotics
US5162512A (en) * 1982-03-09 1992-11-10 Cytogen Corporation Amine derivatives of anthracycline antibodies
US4867973A (en) * 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
JPS59186924A (ja) * 1983-04-08 1984-10-23 Kureha Chem Ind Co Ltd ヒト免疫グロブリン結合抗腫瘍剤
US4545985A (en) * 1984-01-26 1985-10-08 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services Pseudomonas exotoxin conjugate immunotoxins
GB8413464D0 (en) * 1984-05-25 1984-07-04 Erba Farmitalia Anthracycline-anionic polymer conjugates
JPS61155334A (ja) * 1984-12-28 1986-07-15 Teijin Ltd 殺細胞性修飾免疫グロブリン及びその製造方法
FR2584293B1 (fr) * 1985-07-04 1989-03-17 Ire Celltarg Sa Anticorps utiles comme agents de pilotage et conjugues les incorporant

Also Published As

Publication number Publication date
PT86960B (pt) 1992-06-30
NO178954C (no) 1996-07-10
YU48288A (en) 1989-08-31
CZ281193B6 (cs) 1996-07-17
CZ161288A3 (en) 1996-07-17
DK131588D0 (da) 1988-03-11
IL85688A0 (en) 1988-08-31
FI98706C (sv) 1997-08-11
YU46858B (sh) 1994-06-24
DE3808166A1 (de) 1988-09-22
FR2612074B1 (fr) 1991-06-21
AU1288188A (en) 1988-09-15
CN88101810A (zh) 1988-11-09
GR1000059B (el) 1990-06-27
CA1329156C (en) 1994-05-03
HU205266B (en) 1992-04-28
DE3808166C2 (de) 1997-08-28
GB2203154A (en) 1988-10-12
GB2203154B (en) 1991-06-26
MY103231A (en) 1993-05-29
DK173792B1 (da) 2001-11-05
RU2106147C1 (ru) 1998-03-10
JPS63301832A (ja) 1988-12-08
NL8800610A (nl) 1988-10-03
PT86960A (pt) 1988-04-01
NO178954B (no) 1996-04-01
KR880010775A (ko) 1988-10-24
FR2612074A1 (fr) 1988-09-16
HUT46547A (en) 1988-11-28
CN1045621C (zh) 1999-10-13
US5798097A (en) 1998-08-25
FI98706B (sv) 1997-04-30
JP2736255B2 (ja) 1998-04-02
AU622105B2 (en) 1992-04-02
NO881105D0 (no) 1988-03-11
BE1001051A4 (fr) 1989-06-20
FI881158A0 (sv) 1988-03-11
SE8800886L (sv) 1989-09-12
NO881105L (no) 1988-09-12
IT8819746A0 (it) 1988-03-11
FI881158A (sv) 1988-09-12
GR880100148A (en) 1989-01-31
IE64781B1 (en) 1995-09-06
NZ223834A (en) 1990-05-28
GB8805865D0 (en) 1988-04-13
CH678815A5 (sv) 1991-11-15
ATA67488A (de) 1992-05-15
KR0130906B1 (ko) 1998-04-23
ES2006109A6 (es) 1989-04-01
NL195078C (sv) 2003-07-30
IE880701L (en) 1988-09-11
DK131588A (da) 1988-09-12
SE503402C2 (sv) 1996-06-10
AT395375B (de) 1992-12-10

Similar Documents

Publication Publication Date Title
MY104946A (en) Antigen antibody conjugate.
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
EP0743856A4 (en) ANTIG-OCCUPATING HETEROPOLYMERS AND METHODS FOR TREATING AUTOIMMUNE DISEASES BY MEANS OF THEM
NO862641D0 (no) Monoklonalt antistoff for et antigen tilknyttet human karsinoma tumor.
FI963004A0 (sv) Monoklonala antikroppar med immunstimulerande verkan
FI924819A (fi) Chimaera anti-icam-i-antikroppar foer maenniskobruk, foerfaranden foer deras framstaellning samt deras anvaendning
DE3584559D1 (de) Therapeutische antikoerpermittelkonjugate.
AU2614384A (en) Indole-dihydro-indole alkaloids conjugated with antibodies
DE3885355D1 (de) Monoklonale Antikörper.
SE8800886L (sv) Immunglobulinkojugat
DE3586216D1 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
FI853389A0 (fi) Tumoerlaekemedel och foerfarande foer dess framstaellning.
ATE131069T1 (de) Composition comprising at least two different antibodies or fragments thereof.
PT733903E (pt) Processo de dosagem imunologica de cortisol nomeadamente urinario e reagentes utilizados

Legal Events

Date Code Title Description
NUG Patent has lapsed